2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow CIN1: new trials by email Literature Review of CIN1 trials Research Report on CIN1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions ChAdOx1-HPV, MVA-HPV, Placebo - HPV Infection, CIN1 | Phase 1 / Phase 2 | Completed | Barinthus Biotherapeutics | 108 | 2021-03-16 | 2025-08-28 |
| Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females 9-valent HPV Recombinant Vaccine, Placebo - Cervical Cancers, Vulvar Cancer | Phase 1 | Completed | Shanghai Bovax Biotechnology Co., Ltd. | 90 | 2018-10-10 | 2020-01-22 |
Condylomata Acuminata (1) · Papillomavirus Infections (1) · Uterine Cervical Neoplasms (1) · Vaginal Neoplasms (1) · Vulvar Neoplasms (1)
Communicable Diseases (2) · DNA Virus Infections (2) · Disease Attributes (2) · Genital Diseases (2) · Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Sexually Transmitted Diseases (2) · Sexually Transmitted Diseases, Viral (2) · Tumor Virus Infections (2) · Urogenital Diseases (2) · Virus Diseases (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases, Female (1)
Barinthus Biotherapeutics (1) · Shanghai Bovax Biotechnology Co., Ltd. (1)
Belgium (1) · China (1) · Estonia (1) · United Kingdom (1)